talipexole has been researched along with 7-hydroxy-2-n,n-dipropylaminotetralin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batink, H; de Jonge, A; Thoolen, MJ; Timmermans, PB; van Zwieten, PA; Wilffert, B | 1 |
| Bergstrom, DA; Gonzalez, AM; Huang, KX; Kreiss, DS; Sibley, DR; Walters, JR | 1 |
| Mignot, E; Nishino, S; Reid, MS; Sampathkumaran, R; Siegel, JM; Tafti, M | 1 |
| Amano, T; Ishihara, K; Matsubayashi, H; Momiyama, T; Sasa, M; Todo, N | 1 |
| Honda, K; Mignot, E; Nishino, S; Riehl, J | 1 |
| Creese, I; Ouagazzal, AM | 1 |
| Ferrari, F; Giuliani, D; Ottani, A | 1 |
7 other study(ies) available for talipexole and 7-hydroxy-2-n,n-dipropylaminotetralin
| Article | Year |
|---|---|
Quantitative relationships between alpha-adrenergic activity and binding affinity of alpha-adrenoceptor agonists and antagonists.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Blood Pressure; Brain; Cell Membrane; Clonidine; Kinetics; Prazosin; Quinazolines; Rats; Receptors, Adrenergic, alpha; Structure-Activity Relationship; Vasoconstriction | 1984 |
Dopamine receptor agonist potencies for inhibition of cell firing correlate with dopamine D3 receptor binding affinities.
Topics: Aminoquinolines; Animals; Apomorphine; Azepines; Benzothiazoles; Binding, Competitive; CHO Cells; Cricetinae; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Imidazoles; Male; Neurons; Phenethylamines; Piperidines; Pramipexole; Quinolines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Structure-Activity Relationship; Substantia Nigra; Tetrahydronaphthalenes; Thiazoles; Thiophenes; Transfection | 1995 |
Local administration of dopaminergic drugs into the ventral tegmental area modulates cataplexy in the narcoleptic canine.
Topics: Amygdala; Animals; Azepines; Cataplexy; Disease Models, Animal; Dogs; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Electroencephalography; Electromyography; Electrooculography; Female; Globus Pallidus; Male; Microdialysis; Pons; Putamen; Quinpirole; Raclopride; Reticular Formation; Salicylamides; Sleep, REM; Tetrahydronaphthalenes; Ventral Tegmental Area | 1996 |
D2 receptor activation in distinct striatal neurons in comparison with D3 receptors.
Topics: Animals; Azepines; Corpus Striatum; Domperidone; Dopamine; Dopamine D2 Receptor Antagonists; Electrophysiology; In Vitro Techniques; Neurons; Patch-Clamp Techniques; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Synaptic Transmission; Tetrahydronaphthalenes | 1997 |
Dopamine D3 agonists into the substantia nigra aggravate cataplexy but do not modify sleep [corrected].
Topics: Animals; Arousal; Azepines; Cataplexy; Dogs; Dopamine Agonists; Electroencephalography; Electromyography; Electrooculography; Microinjections; Narcolepsy; Receptors, Dopamine D2; Receptors, Dopamine D3; Sleep; Substantia Nigra; Tetrahydronaphthalenes | 1999 |
Intra-accumbens infusion of D(3) receptor agonists reduces spontaneous and dopamine-induced locomotion.
Topics: Animals; Azepines; Benzopyrans; Dopamine; Dopamine Agonists; Locomotion; Male; Nucleus Accumbens; Oxazines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Tetrahydronaphthalenes | 2000 |
Influence of sildenafil on central dopamine-mediated behaviour in male rats.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Administration, Oral; Animals; Azepines; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Male; Ovariectomy; Penile Erection; Phosphodiesterase Inhibitors; Piperazines; Purines; Rats; Rats, Wistar; Sexual Behavior, Animal; Sildenafil Citrate; Stereotyped Behavior; Sulfones; Tetrahydronaphthalenes | 2002 |